Cellular aspects of neoplasia

Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2011

TP53 and gastric carcinoma: a review.

Human mutation·2003

Gastrointestinal neuroendocrine/neuroectodermal tumors.

American journal of clinical pathology·2002

A unique basal pattern of p53 expression in ulcerative colitis is associated with mutation in the p53 gene.

Histopathology·2001

The Vienna classification of gastrointestinal epithelial neoplasia.

Gut·2000

Microsatellite instability and K-ras mutations in patients with ulcerative colitis.

Human pathology·2000

Problems and pitfalls in thyroid cytology.

Monographs in pathology·1997

Errors in cervical smears: minimizing the risk of medicolegal consequences.

Monographs in pathology·1997

Lipomatous tumors.

Monographs in pathology·1996

Vascular tumors: an update with emphasis on the diagnosis of angiosarcoma and borderline vascular neoplasms.

Monographs in pathology·1996

Immunohistochemistry in the differential diagnosis of soft tissue tumors.

Monographs in pathology·1996

Cytogenetics and molecular biology of soft tissue tumors.

Monographs in pathology·1996

Mechanical stress, metabolic reprogramming and stromal remodeling: an emerging paradigm in the bladder cancer mechano-micro-environment.

Frontiers in genetics·2026

YOD1 drives acute kidney injury by deubiquitinating Bax and promoting apoptosis in tubular epithelial cells.

Theranostics·2026

c-Myc: an emerging participant in heart failure.

Frontiers in cardiovascular medicine·2026

Mechanistic insights into the lncRNA-Notch signaling axis in tumors.

Frontiers in cell and developmental biology·2026

Inhibitor of DNA binding 1 in lung cancer and the tumor microenvironment: a testable hypothesis for malignant pleural effusion formation.

Frontiers in immunology·2026

Conditional deletion of Wnt5a in myeloid osteoclast precursors results in low bone mass via disruption of osteoblast migration and focal adhesion dynamics.

Frontiers in cell and developmental biology·2026

Related Experiment Videos

Cellular aspects of neoplasia

Related Concept Videos

Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer.

TP53 and gastric carcinoma: a review.

Gastrointestinal neuroendocrine/neuroectodermal tumors.

A unique basal pattern of p53 expression in ulcerative colitis is associated with mutation in the p53 gene.

The Vienna classification of gastrointestinal epithelial neoplasia.

Microsatellite instability and K-ras mutations in patients with ulcerative colitis.

Problems and pitfalls in thyroid cytology.

Errors in cervical smears: minimizing the risk of medicolegal consequences.

Lipomatous tumors.

Vascular tumors: an update with emphasis on the diagnosis of angiosarcoma and borderline vascular neoplasms.

Immunohistochemistry in the differential diagnosis of soft tissue tumors.

Cytogenetics and molecular biology of soft tissue tumors.

Mechanical stress, metabolic reprogramming and stromal remodeling: an emerging paradigm in the bladder cancer mechano-micro-environment.

YOD1 drives acute kidney injury by deubiquitinating Bax and promoting apoptosis in tubular epithelial cells.

c-Myc: an emerging participant in heart failure.

Mechanistic insights into the lncRNA-Notch signaling axis in tumors.

Inhibitor of DNA binding 1 in lung cancer and the tumor microenvironment: a testable hypothesis for malignant pleural effusion formation.

Conditional deletion of Wnt5a in myeloid osteoclast precursors results in low bone mass via disruption of osteoblast migration and focal adhesion dynamics.

Related Experiment Videos

Cellular aspects of neoplasia

Related Concept Videos

Related Articles